Korean J Urol.  2013 Apr;54(4):277-277.

Letter to the Editor: Is Routine Screening Necessary for Renal Cell Carcinoma in End-Stage Renal Disease Patients?

• Ghadian A

Abstract

No abstract available.

MeSH Terms

Carcinoma, Renal Cell
Kidney Failure, Chronic
Mass Screening

Reference

1. Lee HH, Choi KH, Yang SC, Han WK. Renal cell carcinoma in kidney transplant recipients and dialysis patients. Korean J Urol. 2012. 53:229–233.

2. Einollahi B. Genitourinary neoplasia after kidney transplantation. Nephrourol Mon. 2010. 2:491–496.

3. Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol. 2007. 2:750–756.

4. Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, et al. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? BJU Int. 2012. 110:E570–E573.

5. Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, et al. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol. 2011. 60:366–373.